Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention

The cardiovascular profile of the apelin makes it a promising therapeutic target for heart failure and ischemic heart disease. However, it remains unknown whether apelin affect the clinical outcome of patients with ST elevation myocardial infarction (STEMI) and received percutaneous coronary interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hai-Tao, Chen, Mai, Yu, Jin, Li, Wei-Jie, Tao, Ling, Li, Yan, Guo, Wen-Yi, Wang, Hai-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602953/
https://www.ncbi.nlm.nih.gov/pubmed/25634182
http://dx.doi.org/10.1097/MD.0000000000000449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602953/
https://www.ncbi.nlm.nih.gov/pubmed/25634182
http://dx.doi.org/10.1097/MD.0000000000000449

Ejemplares similares